InvestorsHub Logo
Followers 7
Posts 2799
Boards Moderated 0
Alias Born 01/17/2010

Re: None

Friday, 10/01/2010 6:28:24 PM

Friday, October 01, 2010 6:28:24 PM

Post# of 105534
House of Representatives, today, passed the reauthorization of the “Stem Cell Therapeutic and Research Act,”.

http://www.lifenews.com/bio3189.html

Washington, DC (LifeNews.com) -- The House of Representatives, today, passed the reauthorization of the “Stem Cell Therapeutic and Research Act,” a bill written by pro-life Congressman Chris Smith in 2005. The vote makes it so the provisions of the bill, promoting stem cell research with umbilical cord blood, are in place through 2015.

The landmark bill, HR 2520, was signed into law by President Bush in December 2005 and today's reauthorization was approved by voice vote.

On the House floor, Smith said "it remains one of the best kept secrets in America that umbilical cord blood stem cells and adult stem cells in general are curing people of a myriad of terrible conditions and diseases."

Umbilical cords are a rich, non-controversial source of stem cells, yet hospitals throw millions of them away each year because prior to the law the infrastructure required to properly collect and store them was not available. The 2005 law increased the number of cord blood units and stem cells available for treating patients and expanded research.

“That law created a new nationwide umbilical cord blood stem cell program designed to collect, derive, type and freeze cord blood units for transplantation into patients to mitigate and even cure serious disease and pursuant to the law, also provided stem cells for research,” Smith said. “The new cord blood program was combined in the 2005 law with an expanded bone marrow initiative.”

In Smith’s 2005 law, he named the program after Rep. Bill Young, (FL-10), who spearheaded federal support of bone marrow treatments. The reauthorization of Smith’s bill passed the Senate earlier this week.

The measure authorizes $23 million in federal funds from 2011-2014 and $20 million for fiscal year 2015 for the National Cord Blood Inventory. It also pays $30 million from 2011-2014 and $33 million for fiscal year 2015 for the Bone Marrow Transplant program.

It enhances the studies, demonstration programs, and outreach projects related to cord blood donation and collection to include exploring innovative technologies, novel approaches, and expanding the number of collection sites.

It extends the term of initial and contract extensions from three to five years, making it easier for banks to engage in long-term relationship building with birthing hospitals.

The bill also requires cord blood banks to establish a plan for increasing cord blood unit collections and/or expand the number of collection sites with which they work and provide a plan for becoming self-sufficient. And it requires a GAO report to review studies, demonstration programs, and outreach efforts for the purpose of increasing cord blood unit donation and collection for the NCBI to ensure a high-quality and genetically diverse inventory of cord blood units.

And the bill removes the 150,000 cap on cord blood units to be made available for transplant.

"Each year, over 4 million babies are born in America,” Smith said. "In the past virtually every placenta and umbilical cord was tossed as medical waste. Today, doctors have turned this “medical waste” into medical miracles."

see link for the est of the article.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.